ArticleAlzheimer's & dementia (New York, N. Y.)

Impacts of informant replacement in two industry-sponsored Alzheimer's disease clinical trials.

Mikaela K Nishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.